Company / EPS (Diluted)
Pfizer EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.37
FY2025
5-year range
$0.37 / $5.47
FY2021-FY2025
Trend
-93.2%
vs FY2024
Sector context
#41 of 204
Health Care
What the data says
Pfizer's eps (diluted) of $0.37 is higher than 80% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 10 years, ranging from $0.37 in FY2025 to $5.47 in FY2024.
Based on SEC 10-K filings.
0.37 in FY2025 with a 5-year CAGR of -27.7%. Top quartile in the Health Care sector.
Declined from $3.85 to $0.37 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -39.0%
- 5-Year CAGR
- -27.7%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 204This company $0.37 Sector average -$0.89
▼
+141.3% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 93.2% year-over-year.
- Ranks #41 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.37 | -93.2% |
| FY2024 | $5.47 | +42.1% |
| FY2023 | $3.85 | +136.2% |
| FY2022 | $1.63 | -42.2% |
| FY2021 | $2.82 | +50.8% |
| FY2020 | $1.87 | -46.9% |
| FY2019 | $3.52 | +200.9% |
| FY2018 | $1.17 | +5.4% |
| FY2017 | $1.11 | -21.8% |
| FY2016 | $1.42 | -55.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026